4//SEC Filing
Asterias Biotherapeutics, Inc. 4
Accession 0001209191-15-015731
CIK 0001572552operating
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 9:37 PM ET
Size
7.7 KB
Accession
0001209191-15-015731
Insider Transaction Report
Form 4
Peabody Robert
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2015-02-13+50,000→ 50,000 totalExercise: $3.90Exp: 2025-02-12→ Series A Common Stock (50,000 underlying) - Award
Restricted Stock Units
2015-02-13+3,846→ 3,846 total→ Series A Common Stock (3,846 underlying)
Footnotes (3)
- [F1]These options will vest and become exercisable in 48 equal monthly installments beginning on the one month anniversary of the date of grant.
- [F2]Each restricted stock unit represents a contingent right to receive one share of AST Series A Common Stock.
- [F3]These restricted stock units vest in four equal quarterly installments beginning June 30, 2015.
Documents
Issuer
Asterias Biotherapeutics, Inc.
CIK 0001572552
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001572552
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 9:37 PM ET
- Size
- 7.7 KB